Comparative Effect of Finasteride and Dutasteride on Chromogranin A Levels

    November 2010 in “ Anticancer Research ”
    Alessandro Sciarra, Stefano Salciccia, Gianluca Nesi … Vincenzo Gentile
    Studysummary This study concluded that both finasteride and dutasteride therapies significantly increased chromogranin A serum levels in men with benign prostatic hyperplasia, suggesting an activation of neuroendocrine differentiation.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pubmed.ncbi.nlm.nih.gov →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 2004

    Related research 2

    1. Level-1 Data From the REDUCE Study and the PCPT Data Prostate Cancer · 2015
    2. Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-Alpha Reductase Inhibitors Daehan namseong gwahag hoeji · 2012